Product Development Pipeline

Bio-AMD’s core technical strategy is the development of high-accuracy, high-quality but low-cost rapid diagnostic products. This is an essential requirement for achieving penetration into the POC market that is currently dominated by expensive, slow, non-portable professional products.

The Company has targeted three initial products for development, each using a similar technology platform which can be applied into specific market segments.

Digital Strip Reader (DSR) applied to Digital Home Pregnancy Test (HPT)

Lowered manufacturing cost, quantitative digital test based on Bio-AMD DSR technology, able to compete on price and capability in huge market.

Prothrombin Time (PT) Monitor using COAG technology

Coagulation test able to compete on price and capability to expand established therapeutic drug market.

MPR – Rapid Near-Patient, Multiple Application Diagnostic Technology

Unique, widely applicable technology with a potentially massive market.